Lataa...
Clinical Experience of Using 0.2 % Olopatadin in the Allergic Conjunctivitis Treatment
Purpose: to evaluate the efficacy and safety of complex therapy of allergic conjunctivitis, including 0.2 % olopatodin. Patients and methods: In 40 allergic conjunctivitis (AK) patients were performed: assessment of the intensity of itching and tearing, as well as conjunctival hyperemia and follicul...
Tallennettuna:
Päätekijät: | , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Russo |
Julkaistu: |
Ophthalmology Publishing Group
2019-10-01
|
Sarja: | Oftalʹmologiâ |
Aiheet: | |
Linkit: | https://www.ophthalmojournal.com/opht/article/view/1018 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|